Mitchell Glass's most recent trade in TNF Pharmaceuticals Inc. was a trade of 125,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TNF Pharmaceuticals Inc. | Mitchell Glass | Director, President, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 125,000 | 125,000 | - | - | Employee Stock Option (Right to Buy) |